Immune-Cell-Based Therapy for COVID-19: Current Status

作者：Wang, Yiyuan; Liang, Qinghe; Chen, Fengsheng; Zheng, Jiehuang; Chen, Yan; Chen, Ziye; Li, Ruopeng; Li, Xiaojuan^*

来源：Viruses-Basel, 2023, 15(11): 2148.

DOI：10.3390/v15112148

• SARS-CoV-2
• COVID-19
• cell therapy
• immunotherapy

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic. The interplay between innate and adaptive immune responses plays a crucial role in managing COVID-19. Cell therapy has recently emerged as a promising strategy to modulate the immune system, offering immense potential for the treatment of COVID-19 due to its customizability and regenerative capabilities. This review provides an overview of the various subsets of immune cell subsets implicated in the pathogenesis of COVID-19 and a comprehensive summary of the current status of immune cell therapy in COVID-19 treatment.

• 单位
  南方医科大学